Status:
RECRUITING
PRT for Adolescents With High Functioning Autism
Lead Sponsor:
Stanford University
Conditions:
Autism
Autism Spectrum Disorder High-Functioning
Eligibility:
All Genders
11-14 years
Phase:
NA
Brief Summary
The purpose of this study is to identify improvement in behavioral and social function and changes in the brain following Pivotal Response Treatment (PRT) for Adolescents in highly verbal adolescents ...
Eligibility Criteria
Inclusion
- Clinical Diagnosis of Autism Spectrum Disorder, higher functioning/low support needs
- Intelligence Quotient (IQ): Participants with a Full Scale IQ \> 80 on the Wechsler Abbreviated Scale of Intelligence (WASI-II)
- Right-handed
- No metal in their body/unremovable metal on their body (i.e., braces)
- First language is English
- Must live in the San Francisco Bay Area
- Able and willing to receive intervention weekly for 9 weeks
- Adolescent is interested in improving their social skills
- MRI Compatibility: No major contraindication for MRI.
- Diagnosis of ASD using ADOS-2 and ADI-R.
- No evidence of a genetic, metabolic, or infectious etiology for their autism.
- Primary diagnosis of ASD
- No evidence of significant difficulty during pregnancy, labor, delivery, or immediate neonatal period.
- Stable treatment (e.g., ABA), speech therapy, school placement, psychotropic medication(s) or biomedical intervention(s) for at least 1 month prior to baseline measurements with no anticipated changes during study participation.
- Score of at least 50% or below on at least 4 out of the 9 social target areas in the SLO (administered during pre-measures)
- No evidence of significant difficulty during pregnancy, labor, delivery, or immediate neonatal period.
Exclusion
- History of claustrophobia, previous head injury, serious neurological or medical illness, birth weight less than 4 lb. and/or gestational age \< 34 weeks
- Left-handed
- Braces or any metal in their body
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2026
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT05987761
Start Date
September 1 2023
End Date
August 31 2026
Last Update
March 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford Research Park
Palo Alto, California, United States, 94304